[HTML][HTML] Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine
…, P Price-Abbott, N Formica, V Shinde… - New england journal …, 2020 - Mass Medical Soc
Background NVX-CoV2373 is a recombinant severe acute respiratory syndrome coronavirus
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2 spike …
[HTML][HTML] Efficacy of NVX-CoV2373 Covid-19 vaccine against the B. 1.351 variant
V Shinde, S Bhikha, Z Hoosain, M Archary… - … England Journal of …, 2021 - Mass Medical Soc
Background The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) …
[HTML][HTML] Triple-reassortant swine influenza A (H1) in humans in the United States, 2005–2009
V Shinde, CB Bridges, TM Uyeki, B Shu… - … England Journal of …, 2009 - Mass Medical Soc
Background Triple-reassortant swine influenza A (H1) viruses — containing genes from avian,
human, and swine influenza viruses — emerged and became enzootic among pig herds …
human, and swine influenza viruses — emerged and became enzootic among pig herds …
[HTML][HTML] Respiratory syncytial virus vaccination during pregnancy and effects in infants
Background Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory
tract infection in infants, with the most severe cases concentrated among younger infants…
tract infection in infants, with the most severe cases concentrated among younger infants…
[HTML][HTML] Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis
MD Van Kerkhove, KAH Vandemaele, V Shinde… - PLoS …, 2011 - journals.plos.org
Background Since the start of the 2009 influenza A pandemic (H1N1pdm), the World Health
Organization and its member states have gathered information to characterize the clinical …
Organization and its member states have gathered information to characterize the clinical …
Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults
…, J Slezak, Y Luo, CA Fischetti, V Shinde - Clinical Infectious …, 2019 - academic.oup.com
Background Respiratory syncytial virus (RSV) is an important cause of serious respiratory
illness in older adults. Comparison of RSV and influenza infection in hospitalized older adults …
illness in older adults. Comparison of RSV and influenza infection in hospitalized older adults …
Estimates of mortality attributable to influenza and RSV in the U nited S tates during 1997–2009 by influenza type or subtype, age, cause of death, and risk status
…, C Schuck‐Paim, R Lustig, V Shinde - Influenza and other …, 2014 - Wiley Online Library
… Gonçalo Matias, François Haguinet, and Vivek Shinde are employed by the GlaxoSmithKline
group of companies. Vivek Shinde has stock options in the GlaxoSmithKline group of …
group of companies. Vivek Shinde has stock options in the GlaxoSmithKline group of …
[HTML][HTML] Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome
…, U Narueponjirakul, W Sanasuttipun, V Shinde… - PloS one, 2009 - journals.plos.org
Background Influenza is often not recognized as an important cause of severe or fatal disease
in tropical and subtropical countries in Southeast Asia. The extent to which Oseltamivir …
in tropical and subtropical countries in Southeast Asia. The extent to which Oseltamivir …
The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people
MK Andrew, V Shinde, L Ye, T Hatchette… - The Journal of …, 2017 - academic.oup.com
Background Influenza is an important cause of morbidity and mortality among older adults.
Even so, effectiveness of influenza vaccine for older adults has been reported to be lower …
Even so, effectiveness of influenza vaccine for older adults has been reported to be lower …
[HTML][HTML] Estimates of hospitalization attributable to influenza and RSV in the US during 1997–2009, by age and risk status
…, F Haguinet, C Schuck-Paim, R Lustig, V Shinde - BMC public health, 2017 - Springer
Background Estimates of influenza and respiratory syncytial virus (RSV) burden must be
periodically updated to inform public health strategies. We estimated seasonal influenza- and …
periodically updated to inform public health strategies. We estimated seasonal influenza- and …